Research on depression and its treatment. Covers stress-response biology, ketamine and dopamine-targeting therapies, treatment-resistant cases, and brain mechanisms.
A recent study by University of Wisconsin-Madison researchers found that chronic marital stress can make people more vulnerable to depression. Participants who reported higher marital stress had shorter-lived responses to positive images than those reporting more satisfaction in their unions.
A Vanderbilt study found that two-thirds of ICU patients experience somatic symptoms like weakness, appetite change, and fatigue, surpassing cognitive symptoms. The study highlights a significant public health issue, with millions of patients admitted to ICUs annually.
Researchers have identified a new mechanism by which ghrelin works to limit depression, as well as a potentially powerful neuroprotective drug called P7C3 that may provide greater anti-depressant effects.
A study published in Psychiatry Research found that dopamine replacement therapy commonly used to treat motor symptoms of Parkinson's disease was associated with a decline in cognitive performance among depressed Parkinson patients. Mood in depressed Parkinson's patients was also worse while on dopaminergic medications.
A study published by the American Academy of Neurology found that people with apathy symptoms have smaller brain volumes than those without apathy. Apathy is a lack of interest or emotion, and the findings suggest it may be an indicator of accelerated brain aging.
A telephone-based collaborative care model was effective in managing depression and anxiety in patients with heart disease, improving health-related quality of life. The study found that patients receiving the intervention had greater average improvement in mental health scores at 24 weeks compared to those in the control group.
Saint Louis University researcher Jeffrey Scherrer is investigating the link between chronic opioid use and depression risk. He will analyze medical records of 1 million patients, including those with VA and private sector prescriptions, to understand the impact of opioid exposure on mental health.
The UCLA/RAND community research team won a prestigious award for their 10-year effort to improve depression care in low-income areas. The team's collaborative approach showed that community engagement can provide measurable added value, leading to improved mental and physical health outcomes.
A study published in Biological Psychiatry found that intranasal ketamine conferred an unusually rapid antidepressant effect within 24 hours and was well-tolerated in patients with treatment-resistant major depressive disorder. The results show promise for a new treatment class, targeting the NMDA glutamate receptor.
Residents of poorer Chicago neighborhoods face more life-changing negative events and experience a range of serious health issues due to the complex interplay between traumatic events and lack of resources. The study's findings highlight the need for addressing poverty and providing support for vulnerable populations.
A third of ICU survivors develop depression manifesting as physical symptoms, such as weakness and fatigue, rather than psychological symptoms. Depression is four times more common than PTSD after critical illness, highlighting the need for new treatment approaches focusing on physical rehabilitation.
A study of nearly 63,000 Norwegians found that moderate to severe depression increases the risk of heart failure by 40%. Depression triggers stress hormones and inflammation, which may accelerate heart diseases. Early detection and treatment can help improve outcomes.
Researchers at Oxford Health NHS Foundation Trust and the University of Oxford conducted a UK study on the use of ketamine intravenous infusions in people with treatment-resistant depression. The study found that 29% of patients experienced benefit that lasted at least three weeks, while 15% took over 2 months to relapse.
A new study published in the Journal of Psychiatric Research found that patients injected with Botox showed substantial improvement in their depressive symptoms. The study included 74 depressed subjects who received either Botox or a placebo and showed a 47% decrease in depressive symptoms after six weeks.
Depression patients showed characteristic path length and node attributes differences compared to healthy controls. An artificial neural network algorithm demonstrated the effectiveness of brain network metrics in machine learning research and clinical diagnosis of depression.
A systematic review and meta-analysis of published studies on antidepressants in pregnancy found a strong association between their use and increased preterm birth rates. The study suggests that antidepressant medications may be contributing to the rising trend of preterm births, which can lead to significant health problems and costs.
Researchers found that acupuncture/electroacupuncture combined with Seroxat improves depressive symptoms and reduces obsessive-compulsive and anxiety symptoms. The treatment produces a rapid onset of therapeutic effect.
Researchers found that galanin plays a crucial role in stress mechanisms and influences depression risk, particularly in those with early life neglect or trauma. A new class of antidepressant drugs targeting galanin functionality may provide effective treatment options for patients.
A new five-year study aims to determine whether treating depression in patients with heart failure can help them live longer. The Hopeful Heart trial will include 750 participants who meet severity criteria for heart failure and screen positive for depression.
Researchers at CAMH have developed a nasal spray that delivers a peptide to treat depression, providing an alternative therapeutic approach. The peptide treatment interferes with dopamine receptors, leading to anti-depressant effects and showing potential in relieving symptoms.
A new study by Rutgers University–Camden professor Naomi Marmorstein found that depression in early adolescence predicts obesity in late adolescence among female participants. Conversely, obesity in late adolescence predicts the onset of depression in early adulthood. The study suggests a reciprocal relationship between the two disorde...
Researchers found that problem-solving therapy and dietary coaching were equally effective in preventing major depression among older adults. The study's findings suggest that lifestyle interventions can have a positive effect on well-being and protect against the onset of depression.
A recent study found that active, older caregivers who continue to engage in hobbies and activities are happier after caring for a loved one with a stroke. These caregivers were also better physically healthy and provided higher levels of assistance to the stroke survivor.
Patients who joined a social group and developed a stronger connection with its members experienced reduced symptoms of depression. The study suggests that the 'group' aspect of social interaction is critical in alleviating depression.
A recent systematic review of clinical trials found that vitamin D supplementation had little to no effect on depression. However, additional analyses suggested that vitamin D supplements may help patients with clinically significant depression when combined with traditional antidepressant medication.
Researchers at the University of Montreal found that increased psychological distress and depression symptoms are associated with high cortisol levels, while severe burnout is linked to low cortisol concentrations. This study aims to develop more accurate screening tools for mental health professionals.
A study by Massachusetts General Hospital found that cognitive behavioral therapy addressing mood and treatment management skills improved blood sugar control and reduced depression symptoms in poorly-controlled type 2 diabetes patients. The integrated approach showed faster relief of depression symptoms compared to usual care.
A review of scientific literature indicates that depression should be added to the list of risk factors associated with heart disease. Studies found that depression increases the likelihood of having a heart attack or dying from heart disease.
A population-based cohort study found that older adults with highly active thyroid glands are at a substantially increased risk of developing depression. The study analyzed data from 1,503 participants and found that those with higher TSH levels were more likely to experience depression symptoms over an eight-year period.
Researchers have identified a biological marker for major depression in teenage boys, combining elevated cortisol levels with depressive symptoms. The study found that these individuals are up to fourteen times more likely to develop major depression than those without these traits.
Researchers are leveraging big data from social media platforms like Facebook and Twitter to better understand human behavior and social dynamics. Studies have found differences in communication patterns between parents and children, as well as predictors of postpartum depression.
Researchers found that quitting smoking is associated with lower rates of mood/anxiety disorders and alcohol use disorder. The study analyzed data from over 4,800 daily smokers and found significant improvements in mental health outcomes after quitting or reducing cigarette smoking.
A study by Columbia University's Mailman School of Public Health found that HIV-positive men are more likely to engage in safer sex practices when their moods improve, compared to weeks with worsening moods. Depression was linked to an increased risk of unprotected sex.
A new IUPUI study found that treating depression before cardiovascular disease onset can decrease the risk of future heart attacks and strokes. The study followed 235 older patients with depression, finding a 48% lower risk among those receiving collaborative care.
A recent study published in the European Journal of Preventive Cardiology found a causal link between depression symptoms and an increased risk of coronary heart disease. In contrast, no such association was found with stroke risk. The Whitehall II study, which followed over 10,000 civil servants in the UK for 20 years, suggests that r...
Studies of adult twins and adolescents reveal a strong connection between short or long sleep durations and increased risk of depressive symptoms. Optimal sleep duration is essential for mental health, suggesting that prioritizing sleep may enhance treatment effectiveness for depression.
A large international study found an independent association between diabetes and depression as well as impulse control disorders, including binge-eating and bulimia. Depression increased the risk of diabetes by 30%, while binge-eating disorder increased the risk by 2.6 times.
A multicenter research team led by Cedars-Sinai neurologist Nancy Sicotte used a new automated technique to identify shrinkage of the right hippocampus in women with multiple sclerosis and depressive symptoms. The study found reduced size of the right hippocampus, while the left remained unchanged.
A new study published in Psychosomatic Medicine found that children with depression are more likely to develop obesity, smoking habits, and lower physical activity levels. These factors can increase the risk of heart disease later in life, even as early as teenage years.
Researchers at the University of Bonn have developed an app that measures cellphone use, revealing shocking statistics. The app, dubbed Menthal, analyzes user behavior over six weeks, showing average users activate their smartphones every 12 minutes, and problematic use can lead to addiction-like symptoms.
Researchers at Case Western Reserve University found that rapid improvements in depression symptoms during PTSD treatments are associated with better outcomes. Negative social support from family or friends was also linked to worsening depression symptoms, while transient spikes did not negatively impact treatment progress.
A recent study published in Medical Care found that psychiatric symptoms such as insomnia and emotional distress have a significant impact on work-related outcomes. The study suggests targeting symptoms, rather than disorders, may help lessen the work impact of mental health issues.
Research reveals that levels of depression and anxiety among people with severe rheumatoid arthritis are significantly higher than previously reported. The study suggests that routine screening for depression is crucial, as untreated depression can impact treatment outcomes. The researchers propose modifying the current disease activit...
Research shows that postpartum depression symptoms decrease over time, but 30-50% of affected women experience chronic depression. Factors like age, income, and relationship quality may contribute to a higher risk of chronic depression.
A study found that most pediatric primary care practitioners are reluctant to prescribe antidepressant medications to adolescent patients, even in severe cases. PCPs who had access to on-site mental health care providers and were more knowledgeable about depression were more likely to prescribe antidepressants.
Grand Challenges Canada announces $7.7M project to improve mental health care in developing countries, with mobile phone technologies and innovative approaches to reach underserved populations. The projects aim to increase epilepsy treatment and eliminate barriers for critical mental health services.
A recent study by the University of Toronto found that adults who experienced childhood physical abuse had a delayed recovery from depression. The research highlights the long-term impact of childhood trauma on mental health outcomes.
A study found moderate evidence that mindfulness meditation programs show small improvements in anxiety, depression, and pain. However, there was low evidence of benefits for stress/distress and mental health component of health-related quality of life.
A daily meditation practice of 30 to 40 minutes can improve symptoms of anxiety and depression in patients with various medical conditions. The study found moderate evidence of improvement in symptoms after an eight-week training program in mindfulness meditation.
Women with prenatally diagnosed fear of childbirth are at a higher risk of postpartum depression, even those without a history of depression. The study analyzed data from over 500,000 mothers in Finland and found that nearly one-third of women experiencing postpartum depression had no previous history of depression.
A new study published in the American Heart Association journal Stroke found a link between anxiety and an increased risk of stroke over a 22-year period. People with high anxiety levels had a 33% higher stroke risk than those with low levels, possibly due to smoking, physical inactivity, and stress hormone levels.
Patients undergoing cardiac surgery have a substantially higher risk of depression if they are physically inactive, with 58% of those at-risk progressing to clinical depression. Inactive patients also experience double the risk of depressive symptoms before surgery and postoperatively.
A new study published in Biological Psychiatry reveals that hippocampal volume loss in depression is caused by a reduction in glial cells, not neurons. The research uses female nonhuman primates to clarify the cellular basis of volumetric changes in the brain.
Researchers found that maternal depression was associated with reduced structural connectivity in the right amygdala of newborns. This abnormal microstructure may contribute to a child's vulnerability to mental illness. The study suggests early intervention targeting maternal depression during pregnancy could reduce this risk.
Researchers found vitamin D supplementation significantly improved depression symptoms and reduced neuropathic and sensory pain in women with type 2 diabetes. The study also showed a notable decrease in pain at three and six months following supplementation.
Researchers found that combining modafinil with antidepressants improved depression symptoms and reduced fatigue, which are common relapse triggers. The study suggests modafinil may be a useful supplement for those struggling with depression.
Researchers investigated epigenetic changes in response to maternal cortisol exposure, finding support for prenatal transmission of risk for poor neurodevelopmental outcomes. This study highlights the importance of treating maternal prenatal depression and anxiety to mitigate newborn behavioral problems.
Researchers identify lateral habenula as crucial in cost-benefit decisions, clarifying its role in daily choices and shedding light on depression treatment.
A new study published in Journal of Psychiatric Practice reveals that pregnant women with depression often experience conflict when deciding on treatment. They strongly prefer non-drug treatments like psychotherapy and alternative therapies, citing concerns about antidepressant medications' potential effects on the developing baby.
Researchers have pinpointed specific brain regions and molecules associated with depression and anxiety, offering potential new avenues for understanding and treating these debilitating mental health conditions. The study suggests that targeting certain brain areas and chemical signals may lead to more effective treatments.